Back

Ciliary ARLs drive renal cystogenesis

Van Sciver, R. E.; Forster, A.; Lewis, L.; Caspary, T.

2026-05-05 genetics
10.1101/2025.11.20.689124 bioRxiv
Show abstract

BackgroundPolycystic kidney disease (PKD) is the leading genetic cause of renal failure, resulting in the accumulation of fluid filled cysts and gross enlargement of the kidney. Mutations in PKD1 or PKD2, which encode ciliary polycystin proteins, are the most common cause of PKD. These proteins function in a cilia-dependent cyst activation (CDCA) pathway-one that requires cilia for its pro-cystic function-yet the molecular driver(s) of this pathway are unknown. ARL13B is a regulatory GTPase enriched in cilia and links to renal cystogenesis. ARL13B possesses guanine nucleotide exchange factor (GEF) activity for ARL3, another ARL with links to cilia. MethodsWe used two distinct Arl13b mouse alleles to investigate whether ARL13B is a component of the CDCA pathway: Arl13bV358Aencodes for enzymatically normal ARL13B that is undetectable in cilia, and Arl13bR79Qencodes for cilia-localized ARL13B lacking a residue critical for its ARL3 GEF activity. We used these alleles in a Pkd1-deficient adult mouse model and investigated renal morphology (H&E and cystic index analysis), physiology (blood urea nitrogen measurements), renal fibrosis (picrosirius staining and -smooth muscle actin levels), renal injury (SOX9 immunofluorescent staining and quantification), and Wnt signaling ({beta}-catenin and cyclin D1 protein levels). ResultsWe found that loss of ciliary ARL13B or mutation of a single residue critical for its ARL3 GEF activity suppressed Pkd1-dependent cysts. We observed reductions in kidney size, cystic index, and blood urea nitrogen. We also observed suppression of renal fibrosis, renal injury, and {beta}-catenin and cyclin D1 protein levels. ConclusionsOur results identified a subcellular location and mechanism driving Pkd1-dependent renal cystogenesis. We demonstrated that expression of a critical residue for ARL13Bs GEF activity specifically in cilia is a key mechanism of the CDCA pathway driving renal cystogenesis. Key PointsO_LILoss of ciliary ARL13B suppressed renal cystogenesis in an adult mouse model of polycystic kidney disease (PKD) without ablating cilia C_LIO_LILoss of ciliary ARL13B or mutation of the residue critical for its GEF activity did not affect renal morphology or physiology in a PKD mouse model C_LIO_LIMutation of a residue critical for ARL13B activation of ARL3 suppressed cystic phenotypes in Pkd1-dependent cysts C_LI

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Kidney360
22 papers in training set
Top 0.1%
27.1%
2
Journal of the American Society of Nephrology
52 papers in training set
Top 0.1%
15.4%
3
PLOS ONE
4510 papers in training set
Top 17%
10.6%
50% of probability mass above
4
Kidney International
25 papers in training set
Top 0.1%
6.6%
5
JCI Insight
241 papers in training set
Top 0.6%
5.1%
6
The FASEB Journal
175 papers in training set
Top 0.2%
4.1%
7
Scientific Reports
3102 papers in training set
Top 43%
2.7%
8
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.1%
2.2%
9
Human Molecular Genetics
130 papers in training set
Top 2%
1.6%
10
Physiological Reports
35 papers in training set
Top 0.5%
1.6%
11
PLOS Genetics
756 papers in training set
Top 10%
1.4%
12
Diabetologia
36 papers in training set
Top 0.7%
1.3%
13
Journal of the Endocrine Society
11 papers in training set
Top 0.2%
1.0%
14
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
15
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
16
Kidney International Reports
14 papers in training set
Top 0.3%
0.8%
17
iScience
1063 papers in training set
Top 31%
0.8%
18
Genetics in Medicine
69 papers in training set
Top 1.0%
0.8%
19
Cardiovascular Research
33 papers in training set
Top 1.0%
0.8%
20
Journal of the American Medical Informatics Association
61 papers in training set
Top 2%
0.7%
21
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.7%
22
Physiological Genomics
15 papers in training set
Top 0.5%
0.5%
23
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 1.0%
0.5%
24
eneuro
389 papers in training set
Top 10%
0.5%
25
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.5%